BR100 Increased By (1.34%)
BR30 Increased By (1.79%)
KSE100 Increased By (1.23%)
KSE30 Increased By (1.28%)
AGHA 6.11 Increased By ▲ 0.08 (1.33%)
BECO 4.14 Increased By ▲ 0.28 (7.25%)
BML 60.80 Decreased By ▼ -0.20 (-0.33%)
BOP 28.91 Increased By ▲ 0.82 (2.92%)
CNERGY 11.97 Increased By ▲ 0.23 (1.96%)
CSIL 5.54 Increased By ▲ 0.24 (4.53%)
FCCL 56.32 Increased By ▲ 1.86 (3.42%)
FFL 12.98 Decreased By ▼ -0.09 (-0.69%)
FNEL 1.14 Increased By ▲ 0.03 (2.7%)
KEL 5.81 Increased By ▲ 0.18 (3.2%)
KOSM 5.39 Increased By ▲ 0.05 (0.94%)
LOTCHEM 23.92 Increased By ▲ 0.09 (0.38%)
MLCF 95.70 Increased By ▲ 2.72 (2.93%)
NBP 166.88 Increased By ▲ 3.68 (2.25%)
NCPL 48.30 Increased By ▲ 0.03 (0.06%)
NPL 50.24 Increased By ▲ 0.53 (1.07%)
OGDC 307.79 Increased By ▲ 4.16 (1.37%)
PACE 9.11 Increased By ▲ 0.14 (1.56%)
PAEL 32.30 Increased By ▲ 0.39 (1.22%)
PIBTL 13.09 Increased By ▲ 0.35 (2.75%)
PPL 215.42 Increased By ▲ 2.51 (1.18%)
PRL 85.65 Increased By ▲ 1.31 (1.55%)
PTC 45.70 Increased By ▲ 0.71 (1.58%)
SSGC 23.07 Increased By ▲ 0.24 (1.05%)
TBL 9.02 Increased By ▲ 0.14 (1.58%)
TELE 6.64 Increased By ▲ 0.14 (2.15%)
TPL 25.35 Increased By ▲ 1.09 (4.49%)
TPLP 13.19 Increased By ▲ 1.20 (10.01%)
TREET 23.30 Increased By ▲ 0.16 (0.69%)
TRG 52.35 Increased By ▲ 0.88 (1.71%)
World

Single-shot COVID vaccine in UK could be weeks away

  • A senior government official says the Medicines and Healthcare products Regulatory Agency (MHRA) formal process was “very likely” to start this week
  • The jab, developed by Johnson & Johnson’s vaccine division Janssen, was not yet being considered by the MHRA for formal approval
Published Updated
By

A single-shot vaccine to combat COVID-19 in Britain could be weeks away, with regulators set to begin the approval process this week, The Telegraph reported here.

A senior government source said the Medicines and Healthcare products Regulatory Agency (MHRA) formal process was “very likely” to start this week, according to the report.

The jab, developed by Johnson & Johnson’s vaccine division Janssen, was not yet being considered by the MHRA for formal approval, the report added, citing health sources.

“We are working with them to complete the rolling review process, and we look forward to receiving more data from them as soon as possible,” a department source told The Telegraph.

The news came as the United States is likely nearing the authorization of Johnson & Johnson’s COVID-19 vaccine. On Friday, a panel of outside advisers backed the one-shot immunization.

Comments

Comments are closed for this article.